AtriCure
Focus: AtriCure is a cardiovascular device company focused on ablation and exclusion systems for atrial fibrillation and related cardiac conditions. The company operates as a mid-cap medical device innovator with a mature, commercialized portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About AtriCure
AI assessmentNot HiringNo open roles listed right now. Follow AtriCure to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
AtriClip LAA Exclusion System
Stable
Peak
Phase 4 flagship product with 7 active trials supporting market leadership in structural heart procedures.
LARIAT Suture Delivery Device
Help build intelligence for AtriCure
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.